CASC
CLVS

Coppell Advisory Solutions Corp’s Clovis Oncology, Inc. CLVS Stock Holding History

Coppell Advisory Solutions Corp’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-265
Closed -$12.7K – 1206
2022
Q4 		$12.7K Buy
+265
New +$12.7K ﹤0.01% 577